or Try an Advanced Search...

    Antibody Drug Conjugate Stocks List

    Symbol Grade Name % Change
    CLDX C Celldex Therapeutics, Inc. -0.46
    ADCT C ADC Therapeutics SA -0.46
    ACLX C Arcellx, Inc. -1.91
    KPTI D Karyopharm Therapeutics Inc. -5.33
    MRSN D Mersana Therapeutics, Inc. -0.52
    GMAB D Genmab A/S 0.85
    PYXS F Pyxis Oncology, Inc. -3.66
    TGTX F TG Therapeutics, Inc. -0.64
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Antibody Drug Conjugate stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 5.9
    CNCR C Loncar Cancer Immunotherapy ETF 4.76
    SBIO C ALPS Medical Breakthroughs ETF 3.75
    FBT C First Trust Amex Biotech Index Fund 3.18
    XBI C SPDR S&P Biotech ETF 2.88
    View all Antibody Drug Conjugate ETFs...
    Compare ETFs
    Compare PBE to FBT Compare PBE to SBIO Compare SBIO to XBI

        Antibody Drug Conjugate Stocks Recent News

        Date Stock Title
        Apr 15 ACLX Peering Into Arcellx's Recent Short Interest
        Apr 15 GMAB Roche reports survival data for new dual-acting lymphoma drug
        Apr 15 TGTX TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
        Apr 15 GMAB Transactions in Connection with Share Buy-back Program Genmab
        Apr 12 TGTX TG Therapeutics: BRIUMVI Development Could Lead To Great Results
        Apr 9 CLDX Down -14.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Celldex (CLDX)
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics
        Antibody Drug Conjugate

        An Antibody Drug Conjugate (ADC) is a type of targeted therapy used to treat cancer. It is a combination of an antibody, which is a protein that binds to a specific target on cancer cells, and a drug, which is a chemical that kills the cancer cells. The antibody is linked to the drug, allowing it to be delivered directly to the cancer cells. This targeted approach reduces the side effects of traditional chemotherapy, which can damage healthy cells as well as cancer cells.

        Browse All Tags